Report Description Table of Contents How Are Portable Nuclear Imaging and Surgical Oncology Applications Driving the Global Mobile Gamma Cameras Market? – (Updated On: 29th-Oct-2026) According to Strategic Market Research, the global Mobile Gamma Cameras Market was valued at USD 63.93 million in 2025 and is projected to reach USD 92.21 million by 2032, growing at a CAGR of 5.37% during 2026–2032. Hospitals, nuclear medicine departments, and specialized surgical centers use portable and handheld gamma cameras for sentinel lymph node localization, thyroid and parathyroid imaging, and selected bedside diagnostic procedures. Demand is concentrated in facilities requiring nuclear imaging capabilities beyond conventional fixed-camera installations. Nuclear medicine procedure volumes provide an important measure of the established imaging infrastructure. According to the Society of Nuclear Medicine and Molecular Imaging (SNMMI), approximately 20 million diagnostic nuclear medicine scans are performed annually in the United States, with around 2,830 hospitals providing nuclear medicine services to Medicare beneficiaries. These figures cover the broader nuclear medicine sector, but indicate the scale of clinical facilities where portable gamma cameras may complement conventional imaging systems, particularly for bedside examinations and specialized procedures. Breast cancer surgery represents an important clinical application for portable gamma imaging. The World Health Organization estimates that approximately 2.4 million women were diagnosed with breast cancer worldwide in 2024. Sentinel lymph node assessment is used in selected breast cancer surgeries, with portable gamma cameras providing additional imaging support for radiotracer localization. Their clinical use depends on surgical requirements, available equipment, and institutional imaging protocols. Portable imaging systems are already commercially available for different hospital requirements. Digirad's Ergo gamma camera is offered through purchase, rental, and leasing arrangements for hospitals and outpatient facilities. Its mobile configuration supports selected nuclear medicine examinations at the patient's bedside, including situations where transferring patients to dedicated imaging rooms is difficult. Clinical evaluation of newer portable imaging systems is extending beyond conventional diagnostic applications. In October 2026, Serac Imaging Systems reported completion of a 150-patient clinical study evaluating its investigational Seracam gamma-optical camera. The research included thyroid and parathyroid imaging, sentinel node localization, and yttrium-90 imaging. The findings provide clinical evidence for further development of portable imaging equipment, with regulatory clearance and broader clinical validation remaining important before routine adoption. Manufacturers are also investing in the modernization of mobile nuclear imaging equipment. In April 2026, Catalyst MedTech acquired X3D, a company associated with approximately 5,000 nuclear imaging systems worldwide. In May 2026, Catalyst presented its Ergo+ development concept, targeting improvements in camera positioning and clinical operation. The acquisition and ongoing product development reflect investment in nuclear imaging manufacturing capabilities and portable equipment portfolios. Which Subsegments Are Leading the Mobile Gamma Cameras Market, and Where Are the Strongest Emerging Opportunities? By Product Type: Handheld Cameras Lead Compact Surgical Imaging Adoption Largest and Fastest-Growing Subsegment – Handheld Gamma Cameras Handheld gamma cameras accounted for approximately 38% of the global Mobile Gamma Cameras Market in 2025, equivalent to USD 24.29 million, with an anticipated CAGR of 6.50% during 2026–2032. Their market position is supported by growing adoption in intraoperative nuclear medicine, particularly sentinel lymph node mapping, tumor localization, and radio-guided surgical procedures. Compact, portable designs enable close-range imaging directly within operating rooms, improving surgical precision and workflow flexibility. Increasing integration with mobile nuclear imaging systems further strengthens their commercial presence across specialized surgical facilities. By Detector Technology: Scintillation Leads as Semiconductor Detectors Expand Largest Subsegment – Scintillation-Based Gamma Cameras Scintillation-based gamma cameras accounted for an estimated 52% share of the global Handheld Gamma Cameras Market in 2025, valued at USD 33.24 million, and are projected to grow at a CAGR of 3.70% during 2026–2032. Their leading position reflects the established use of scintillation detectors, commonly associated with Anger camera technology, for converting gamma radiation into measurable light signals. Compact scintillation-based systems support radiotracer localization, sentinel lymph node mapping, and intraoperative tumor identification, strengthening their commercial relevance across surgical oncology and nuclear medicine applications. Fastest-Growing Subsegment – Semiconductor-Based Gamma Cameras (CZT/CdTe) Semiconductor-based handheld gamma cameras accounted for an estimated 38% market share, representing USD 24.29 million in 2025, and are projected to achieve the fastest CAGR of 7.20% during 2026–2032. Incorporating Cadmium Zinc Telluride (CZT) and Cadmium Telluride (CdTe) direct-conversion detectors, semiconductor-based handheld gamma cameras offer compact alternatives to conventional scintillation crystal and photomultiplier tube systems. Their lightweight construction, improved portability, and suitability for intraoperative imaging support growing adoption across surgical oncology, sentinel lymph node localization, and radioguided procedures. By Application: Sentinel Mapping Leads as Tumor Localization Expands Largest Subsegment – Sentinel Lymph Node Mapping Sentinel lymph node mapping dominated the Handheld Gamma Cameras Market with an estimated 49% share in 2025, equivalent to USD 31.33 million, and is projected to grow at a CAGR of 4.60% during 2026–2032. Handheld gamma cameras enable intraoperative nuclear imaging, allowing surgeons to precisely locate sentinel lymph nodes during breast cancer and melanoma procedures. Their ability to support real-time lymphatic mapping, improve surgical localization, and facilitate targeted biopsies strengthens their clinical adoption across surgical oncology departments and specialized cancer treatment centers. Fastest-Growing Subsegment – Intraoperative Tumor Localization Intraoperative tumor localization accounted for an estimated 31% of the Handheld Gamma Cameras Market, contributing USD 19.82 million in 2025, and is projected to register the fastest CAGR of 6.65% during 2026–2032. Handheld gamma cameras support precise tumor identification and sentinel lymph node (SLN) mapping during oncological surgeries by providing real-time, two-dimensional imaging within operating rooms. Their ability to complement conventional gamma probes, enhance surgical localization accuracy, and support targeted tissue removal is strengthening their clinical adoption across specialized cancer treatment centers. By End User: Hospitals Lead as Ambulatory Surgical Use Expands Largest Subsegment – Hospitals Hospitals dominated the global Handheld Gamma Cameras Market, accounting for an estimated 67% market share in 2025, representing USD 42.83 million, with a projected CAGR of 4.75% during 2026–2032. Hospitals increasingly utilize handheld gamma cameras for intraoperative radiotracer localization, sentinel lymph node mapping, and targeted nuclear medicine imaging. Their compact, portable design enables surgeons and nuclear medicine specialists to perform localized imaging directly in operating rooms or at patients’ bedsides, improving procedural flexibility and supporting precise surgical decision-making across oncology and specialized healthcare departments. Fastest-Growing Subsegment – Ambulatory Surgical Centers Ambulatory Surgical Centers (ASCs) accounted for an estimated 7% of the global Handheld Gamma Cameras Market, equivalent to USD 4.48 million in 2025, and are projected to register the fastest CAGR of 6.80% during 2026–2032. Increasing adoption of handheld gamma cameras in outpatient surgical settings is supporting precise radioguided procedures, particularly sentinel lymph node mapping and tumor localization. Their portability, convenient intraoperative use, and compatibility with minimally invasive surgical workflows are strengthening adoption across ASCs, expanding access to specialized nuclear medicine-guided interventions. By Geography: North America Leads as Asia-Pacific Expands Nuclear Imaging Largest Regional Market – North America North America accounted for an estimated 38% share of the global Handheld Gamma Cameras Market in 2025, equivalent to USD 24.29 million, with a projected CAGR of 4.50% during 2026–2032. Regional market expansion is supported by the growing adoption of compact gamma imaging systems for intraoperative tumor localization, sentinel lymph node mapping, and targeted nuclear medicine procedures. The shift toward decentralized healthcare delivery, outpatient surgical services, and flexible point-of-care imaging is further strengthening the commercial adoption of handheld gamma cameras across hospitals and specialized oncology centers. Fastest-Growing Regional Market – Asia-Pacific Asia-Pacific Handheld Gamma Cameras Market accounted for an estimated 25% of the global market in 2025, valued at USD 15.98 million, and is projected to register the fastest regional CAGR of 7.15% during 2026–2032. Market expansion is supported by increasing adoption of handheld gamma cameras for intraoperative tumor localization, sentinel lymph node mapping, and radioguided surgical procedures. Expanding nuclear medicine infrastructure, rising oncology-related surgical procedures, and growing investment in specialized cancer treatment facilities across China, Japan, and South Korea further strengthen regional market prospects. How Are Key Clinical and Industrial Applications Defining the Role of Mobile Gamma Cameras? Sentinel Lymph Node Mapping in Cancer Surgery Sentinel lymph node mapping represents a major clinical application of mobile gamma cameras, particularly in breast cancer and melanoma surgery. The application accounted for an estimated 49% market share, equivalent to USD 31.33 million in 2025 revenue. Portable gamma imaging helps surgeons identify radiotracer-avid lymph nodes and supports targeted surgical removal. With approximately 2.3 million new female breast cancer cases worldwide in 2022, according to the International Agency for Research on Cancer, the clinical population requiring cancer staging creates substantial opportunities for specialized radioguided imaging equipment. Intraoperative Tumor Localization and Radioguided Surgery Intraoperative tumor localization accounted for an estimated 31% market share, representing USD 19.82 million in 2025 revenue, with a projected CAGR of 6.65% during 2026–2032. Mobile gamma cameras provide localized imaging during selected oncological procedures, helping surgeons visualize radiotracer accumulation and identify targeted tissues. Hybrid gamma-optical systems, such as Seracam, offer complementary visual information by combining radioactive tracer localization with optical imaging, strengthening their potential role in specialized surgical navigation. Parathyroid Gland Localization Mobile gamma cameras support selected parathyroid operations by helping surgeons identify hyperfunctioning parathyroid tissue following radiotracer administration. Their application is particularly relevant in focused parathyroidectomy, where localized imaging can complement conventional gamma probes and preoperative examinations. Portable imaging technology offers additional intraoperative confirmation, supporting specialized endocrine surgical workflows and creating equipment opportunities for hospitals and endocrine surgery centers. Thyroid Imaging and Functional Assessment Thyroid scintigraphy represents an established nuclear medicine application where compact gamma cameras can help visualize radiotracer distribution and assess functional thyroid abnormalities. Portable systems enable selected examinations in clinical environments with limited access to conventional imaging facilities. Their commercial relevance is concentrated in nuclear medicine departments, specialized endocrine clinics, and facilities seeking flexible imaging capabilities. Adoption depends on clinical protocols, radiopharmaceutical availability, and equipment suitability. Cardiac Nuclear Imaging Mobile gamma cameras support selected cardiac nuclear imaging procedures by providing compact equipment for focused radiotracer examinations. Solid-state imaging systems, including Digirad's Ergo and 2020tc platforms, illustrate the application of semiconductor detector technology in mobile nuclear medicine. Specialized cardiac imaging opportunities are associated with hospitals seeking flexible equipment deployment and selected clinical workflows. Comprehensive myocardial perfusion imaging continues to require appropriate dedicated imaging capabilities. Bedside and Intensive Care Nuclear Imaging Bedside nuclear imaging enables selected gamma camera examinations for patients requiring intensive monitoring or experiencing mobility limitations. Portable systems can support imaging within intensive care units and other hospital departments, reducing the need for patient transportation when suitable protocols are available. This application is commercially relevant to hospitals with multidisciplinary care services, complex patient populations, and established nuclear medicine infrastructure. Industrial Radiation Safety and Emergency Response Beyond medical imaging, mobile gamma cameras support radioactive-source localization, contamination mapping, and radiation monitoring in nuclear facilities and emergency response environments. Mirion's iPIX uses portable gamma imaging for radioactive-source visualization, while NuviaTech's NuVISION employs CZT-based spectrometric technology for radiation localization and isotope identification. Nuclear decommissioning projects, industrial radiation safety programs, and emergency preparedness activities represent specialized purchasing opportunities for portable gamma imaging equipment. Which Leading Companies Are Advancing Mobile Gamma Camera Technologies and Specialized Imaging Applications? Digirad Corporation – Mobile Solid-State Nuclear Imaging Digirad Corporation is an established participant in mobile nuclear imaging, particularly through its Ergo and 2020tc gamma camera systems. These platforms employ solid-state detector technology and support nuclear medicine applications requiring flexible equipment positioning. The company's imaging portfolio is relevant to cardiac examinations, localized diagnostic studies, and hospital nuclear medicine workflows. Digirad's commercial position is supported by its experience in semiconductor-based gamma imaging and the deployment of mobile systems across specialized healthcare environments. Its technology also demonstrates the commercial potential of solid-state detectors in compact nuclear imaging equipment. The wider Mobile Gamma Cameras Market, estimated at USD 63.93 million in 2025, provides opportunities for established suppliers to address equipment replacement, specialized diagnostic applications, and portable imaging requirements. This market figure represents the overall industry rather than Digirad's individual revenue. Dilon Technologies – Dedicated Breast and Surgical Gamma Imaging Dilon Technologies is a specialized medical imaging company associated with breast-specific gamma imaging and radioguided surgical localization. Its GammaLoc technology is associated with the localization of radiotracer-avid tissue during selected surgical procedures, while its breast imaging activities demonstrate expertise in focused nuclear medicine applications. The company's commercial relevance is closely connected to breast cancer diagnosis and radioguided surgery. According to the International Agency for Research on Cancer, approximately 2.3 million women were newly diagnosed with breast cancer worldwide in 2022, establishing a substantial clinical population requiring diagnostic assessment and, in selected cases, surgical staging. The estimated USD 31.33 million sentinel lymph node mapping segment in 2025 illustrates the commercial importance of localized surgical gamma imaging, although this figure is not attributable specifically to Dilon Technologies. Other Important Companies and Their Roles: Spectrum Dynamics Medical: Develops semiconductor-based CZT nuclear imaging technologies, particularly for advanced cardiac SPECT applications, contributing expertise in solid-state gamma detection and image reconstruction. Crystal Photonics GmbH: Specializes in radiation detection and nuclear imaging technologies, including gamma imaging components and specialized detection solutions relevant to compact nuclear medicine systems. Mediso Medical Imaging Systems: Manufactures nuclear medicine imaging equipment and integrated SPECT technologies, supporting clinical diagnostic imaging and specialized nuclear medicine applications. Serac Imaging Systems: Develops the Seracam portable hybrid gamma-optical camera, combining radioactive tracer visualization with optical imaging for localized medical applications. Mirion Technologies: Supplies iPIX portable gamma imaging equipment for radioactive-source localization, contamination assessment, and nuclear facility radiation safety. NuviaTech: Provides NuVISION portable gamma imaging technology incorporating CZT detection and spectrometric capabilities for industrial radiation mapping, isotope identification, and emergency response applications. Analyst Commentary: How Will Compact Detectors and Surgical Integration Shape Equipment Purchasing? The mobile gamma cameras market is increasingly influenced by the shift toward compact, procedure-specific nuclear imaging solutions that support surgical precision and flexible clinical workflows. The strongest commercial opportunities lie in semiconductor-based gamma detectors, hybrid gamma-optical imaging, and intraoperative visualization, particularly in specialized oncology and endocrine surgery. Greater emphasis on equipment portability, clinical utilization, and integration with existing surgical infrastructure is expected to shape procurement decisions, while manufacturers offering cost-efficient, high-performance imaging systems will be better positioned to capture opportunities in specialized healthcare settings. Mobile Gamma Cameras Market Report Coverage Table Report Attribute Details Forecast Period 2026 – 2032 Market Size Value in 2025 USD 63.93 Million Revenue Forecast in 2032 USD 92.21 Million Overall Growth Rate CAGR of 5.37% (2026 – 2032) Base Year for Estimation 2025 Historical Data 2019 – 2024 Unit USD Million, CAGR (2026 – 2032) Segmentation By Product Type, By Detector Technology, By Application, By End User, By Geography By Product Type Handheld Gamma Cameras, Portable Cart-Based Gamma Cameras, Compact Mobile Gamma Camera Systems By Detector Technology Scintillation-Based Gamma Cameras, Semiconductor-Based Gamma Cameras (CZT/CdTe), Hybrid Detector Gamma Cameras By Application Sentinel Lymph Node Mapping, Intraoperative Tumor Localization, Thyroid and Parathyroid Imaging By End User Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers By Region North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Country Scope U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa Market Drivers Adoption of radioguided surgical imaging, requirements for sentinel lymph node localization, advances in compact semiconductor detectors, development of hybrid gamma-optical systems, hospital investment in portable nuclear imaging Customization Option Available upon request Frequently Asked Question About This Report Q1. What clinical applications are generating demand in the market? A1. Sentinel lymph node mapping leads with an estimated 49% share in 2025. Selected tumor-localization and endocrine procedures also create equipment requirements. Purchasing depends on procedure volumes and whether portable imaging adds value to existing surgical and nuclear medicine workflows. Q2. How are detector advancements shaping industry innovation? A2. Semiconductor detectors support compact systems that are easier to position near patients or within operating rooms. The report projects this technology category to grow at a CAGR of 7.20% during 2026–2032. Suppliers can differentiate through portability and imaging performance suited to specific procedures. Q3. Why do hospitals account for the largest market share? A3. Hospitals hold an estimated 67% share in 2025 because they combine nuclear medicine infrastructure with surgical departments and specialist staff. Equipment can serve selected bedside and intraoperative examinations. Access to radiopharmaceuticals and established imaging protocols remains important to practical utilization. Q4. What emerging technologies could influence the industry’s future? A4. Hybrid gamma-optical systems combine radiotracer localization with visual information about the examination area. Serac’s investigational Seracam illustrates this approach. Broader adoption will depend on regulatory clearance and evidence that the additional imaging information improves clinical workflows. Q5. How are flexible purchasing arrangements supporting market development? A5. Purchase, leasing and rental options give facilities different ways to access equipment. Digirad offers these arrangements for its Ergo system. They can help providers align equipment spending with expected utilization and assess whether portable imaging fits their service requirements. Q6. What factors could limit wider market adoption? A6. Facilities need suitable procedure volumes, trained personnel and reliable radiopharmaceutical access to use equipment effectively. Portable systems must also fit existing clinical protocols. Manufacturers need to demonstrate clear procedural value to justify investment alongside conventional imaging equipment. Q7. Which region offers the fastest market growth potential? A7. Asia-Pacific is projected to record the fastest regional CAGR of 7.15% during 2026–2032. Expanding nuclear medicine infrastructure and specialized oncology services support this outlook. China, Japan, India, South Korea and Australia offer opportunities for suppliers serving procedure-specific imaging needs. Sources: World Health Organization – Estimates That 2.4 Million Women Were Diagnosed With Breast Cancer Worldwide in 2024, Providing Disease-Burden Context for Surgical Oncology and Lymph-Node Assessment WHO – Global Breast Cancer Estimates: Incidence, Mortality, and Survival U.S. Government Accountability Office – Its June 2026 Report States That Approximately 20 Million Medical Procedures Using Isotopes Are Performed Annually in the United States; This Covers the Broader Medical-Isotope Sector GAO – Managing Critical Isotopes: Medical Procedure Demand and Supply Requirements U.S. FDA – Cleared Digirad’s Ergo Imaging System Under K123408 on January 15, 2013, With Indications Including Lymphatic Scintigraphy, Parathyroid Scintigraphy, and Intraoperative Imaging With Sterile Drapes FDA – Ergo Imaging System: Regulatory Clearance and Clinical Indications U.S. FDA – Oncovision’s Sentinella 102 and Sentinella 102 Horus Received Clearance on August 18, 2016, With Indications Including Bedside, Emergency-Room, Intensive-Care, and Intraoperative Imaging FDA – Sentinella Mobile Gamma Cameras: Clearance K162052 and Intended Applications U.S. FDA – Describes Dilon’s 6800 Acella as a Portable, Small-Field-of-View Gamma Camera for Imaging Radiopharmaceutical Distribution in Its 2011 Regulatory Documentation FDA – Dilon 6800 Acella: Portable Gamma Camera Technology and Intended Use Digirad – Offers the Portable Ergo Gamma Camera Through Purchase, Lease, and Rental Arrangements, With Applications Across Operating Rooms, Intensive Care, Hospital Wards, and Outpatient Facilities Digirad – Ergo Portable Gamma Camera: Clinical Applications and Acquisition Options Universal Medical Resources – Markets SoloMobile for Thyroid, Parathyroid, Hepatobiliary, Cardiac, and Sentinel-Node Imaging, With Approximately One Hour of Imaging From a Fully Charged Battery Universal Medical – SoloMobile Gamma Camera: Applications and Portable Operation Crystal Photonics – Describes CrystalCam as a Handheld CZT Gamma Camera Weighing Less Than 800 Grams for Radiotracer Localization; Its Website Currently States That It Is Unavailable as a Medical Device in Europe Crystal Photonics – CrystalCam: Handheld Gamma Imaging and Commercial Availability Serac Imaging Systems – Reported a Completed 150-Patient Seracam Study on October 19, 2026, Covering Thyroid, Parathyroid, Sentinel-Node, and Yttrium-90 Imaging; The Camera Remains for Investigational Clinical Use Serac – October 2026 Portable Gamma-Optical Camera Study Presented at EANM Catalyst MedTech – Announced Its Acquisition of X3D on April 2, 2026, Reporting Approximately 5,000 Installed Systems Across X3D’s Broader Nuclear-Imaging Portfolio, Alongside Catalyst’s Existing Digirad Ergo Platform Catalyst MedTech – X3D Acquisition and Expansion of Nuclear-Imaging Manufacturing Capabilities Catalyst MedTech – Its May 2026 Announcement Described an Ergo+ Development Demonstration Featuring Proposed Motorized Positioning and Touchscreen Workflows; Ergo+ Was Identified as Not FDA-Cleared or Commercially Available in the United States Catalyst MedTech – Ergo+ Development Showcase and Imaging-System Modernization Plans Mirion Technologies – Supplies the 2.5-Kilogram iPIX Portable Gamma-Ray Imaging System for Radioactive-Source Localization, Contamination Mapping, Nuclear Decommissioning, and Emergency Response Mirion – iPIX Portable Gamma Imaging: Industrial Radiation Safety Applications NUVIATech Instruments – Provides NuVISION, a Portable CZT-Based Gamma Camera for Radioactive-Source Localization, Radioisotope Identification, and Radiation-Risk Assessment NUVIATech – NuVISION Portable Gamma Camera: Industrial Imaging and Source Identification Serac Imaging Systems – Announced Its First Commercial Seracam Installation at Sellafield on July 20, 2026, for Radiological Characterization of Facilities Scheduled for Decommissioning Serac – July 2026 Seracam Sale to Sellafield for Industrial Gamma Imaging Table of Contents - Global Mobile Gamma Cameras Market Report (2026–2032) Executive Summary Market Overview Market Attractiveness by Product Type, Detector Technology, Application, End User, and Region Strategic Insights from Key Executives (CXO Perspective) Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Summary of Market Segmentation by Product Type, Detector Technology, Application, End User, and Region Portable Nuclear Imaging and Surgical Oncology Applications Clinical Developments and Product Innovation Through 2032 Market Share Analysis Leading Players by Revenue and Market Share Market Share Analysis by Product Type, Detector Technology, Application, and End User Regional Market Share Analysis Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Investment Opportunities in the Mobile Gamma Cameras Market Key Developments and Innovations Mergers, Acquisitions, and Strategic Partnerships High-Growth Segments for Investment Opportunities in Handheld Gamma Cameras and Compact Mobile Gamma Camera Systems Investment Opportunities in Semiconductor-Based Gamma Cameras (CZT/CdTe) Hybrid Gamma-Optical Imaging and Intraoperative Tumor Localization Sentinel Lymph Node Mapping and Radioguided Surgical Applications Portable Nuclear Imaging for Bedside and Specialized Diagnostic Procedures Industrial Radiation Safety, Radioactive-Source Localization, and Emergency Response Applications Market Introduction Definition and Scope of the Study Market Structure and Key Findings Overview of Top Investment Pockets Portable and Handheld Gamma Cameras in Nuclear Medicine Role of Mobile Gamma Imaging in Surgical Oncology and Sentinel Lymph Node Mapping Clinical Importance of Thyroid and Parathyroid Imaging Bedside Imaging and Specialized Hospital Applications Overview of Detector Technologies and Imaging Platforms Research Methodology Research Process Overview Primary and Secondary Research Approaches Market Size Estimation and Forecasting Techniques Data Triangulation and Segment-Level Forecasting Approach Historical Market Assessment (2019–2024) Base Year Market Assessment (2025) Forecast Methodology and Assumptions (2026–2032) Market Dynamics Key Market Drivers Challenges and Restraints Impacting Growth Emerging Opportunities for Stakeholders Impact of Regulatory Requirements and Clinical Validation Role of Nuclear Medicine Infrastructure and Portable Diagnostic Equipment Advances in Semiconductor-Based Detectors and Hybrid Gamma-Optical Imaging Clinical Workflow Integration and Equipment Procurement Trends Importance of Regulatory Clearance and Broader Clinical Validation for Investigational Imaging Systems Impact of Hospital Infrastructure, Oncology Procedures, and Specialized Surgical Services Global Mobile Gamma Cameras Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type: Handheld Gamma Cameras Portable Cart-Based Gamma Cameras Compact Mobile Gamma Camera Systems Market Analysis by Detector Technology: Scintillation-Based Gamma Cameras Semiconductor-Based Gamma Cameras (CZT/CdTe) Hybrid Detector Gamma Cameras Market Analysis by Application: Sentinel Lymph Node Mapping Intraoperative Tumor Localization Thyroid and Parathyroid Imaging Market Analysis by End User: Hospitals Specialty Cancer Centers Ambulatory Surgical Centers Market Analysis by Region: North America Europe Asia-Pacific Latin America Middle East & Africa Leading and Fastest-Growing Subsegments Handheld Gamma Camera Adoption and Compact Surgical Imaging Scintillation-Based and Semiconductor-Based Detector Technologies Clinical Applications in Surgical Oncology and Nuclear Medicine Regional Market Analysis North America Mobile Gamma Cameras Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Detector Technology, Application, and End User Nuclear Medicine Services and Specialized Cancer Surgery Programs Mobile Imaging Equipment Procurement and Hospital Adoption Country-Level Breakdown: United States Canada Europe Mobile Gamma Cameras Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Detector Technology, Application, and End User Specialized Nuclear Imaging Services and Clinical Adoption Oncology Imaging and Surgical Workflow Integration Country-Level Breakdown: Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific Mobile Gamma Cameras Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Detector Technology, Application, and End User Nuclear Medicine Infrastructure Investment and Specialist Healthcare Capacity Oncology Imaging and Radioguided Surgical Applications Country-Level Breakdown: China Japan India South Korea Australia Rest of Asia-Pacific Latin America Mobile Gamma Cameras Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Detector Technology, Application, and End User Specialized Diagnostic Imaging Investment and Oncology Service Development Country-Level Breakdown: Brazil Rest of Latin America Middle East & Africa Mobile Gamma Cameras Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Product Type, Detector Technology, Application, and End User Specialist Hospital Infrastructure and Nuclear Medicine Capabilities Advanced Surgical Imaging and Diagnostic Service Development Country-Level Breakdown: Saudi Arabia United Arab Emirates South Africa Rest of Middle East & Africa Clinical Applications and Technology Analysis Sentinel Lymph Node Mapping in Cancer Surgery Intraoperative Tumor Localization and Radioguided Surgery Parathyroid Gland Localization Thyroid Imaging and Functional Assessment Cardiac Nuclear Imaging Bedside and Intensive Care Nuclear Imaging Industrial Radiation Safety and Emergency Response Portable Gamma Imaging for Radioactive-Source Localization and Contamination Mapping Scintillation-Based Detector Technologies Semiconductor-Based CZT/CdTe Detector Technologies Hybrid Gamma-Optical Imaging Systems Competitive Intelligence and Benchmarking Leading Key Players: Digirad Corporation Dilon Technologies Spectrum Dynamics Medical Crystal Photonics GmbH Mediso Medical Imaging Systems Serac Imaging Systems Mirion Technologies NuviaTech Catalyst MedTech Bruker Corporation Thermo Fisher Scientific Inc. Siemens Healthineers Competitive Landscape and Strategic Insights Benchmarking Based on Detector Technology, Portability, Imaging Performance, Clinical Applications, and Regional Presence Product Portfolio and Equipment Procurement Strategy Analysis Handheld and Cart-Based Gamma Camera Positioning Semiconductor Detector and Hybrid Imaging Technology Competitiveness Clinical Validation, Regulatory Clearance, and Product Development Strategic Partnerships, Acquisitions, and Manufacturing Capabilities Product Innovation and Commercial Development Through 2032 Appendix Abbreviations and Terminologies Used in the Report References and Sources Market Definitions and Segmentation Criteria Historical Data Coverage (2019–2024) Base Year Definitions and Assumptions (2025) Forecast Methodology and Assumptions (2026–2032) Regional and Country Coverage Clinical Evidence and Investigational Technology Considerations List of Tables Market Size by Product Type, Detector Technology, Application, End User, and Region (2026–2032) Historical Market Size and Volume (2019–2024), Base Year Market Size Analysis (2025), and Forecasts (2026–2032) Regional Market Breakdown by Segment Type (2026–2032) Country-Level Market Analysis Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Competitive Benchmarking of Leading Mobile Gamma Camera and Nuclear Imaging Vendors Detector Technology Comparison: Scintillation-Based, Semiconductor-Based (CZT/CdTe), and Hybrid Detector Gamma Cameras Clinical Applications Across Sentinel Lymph Node Mapping, Intraoperative Tumor Localization, and Thyroid and Parathyroid Imaging Portable Nuclear Imaging and Industrial Radiation Safety Applications Product Innovation, Acquisitions, and Development Milestones in 2026 List of Figures Market Drivers, Challenges, Opportunities, and Restraints Regional Market Snapshot Competitive Landscape by Market Share Growth Strategies Adopted by Key Players Market Share by Product Type, Detector Technology, Application, and End User (2025 vs. 2032) Global Mobile Gamma Cameras Ecosystem and Value Chain Analysis Regional Market Comparison Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Semiconductor-Based Detector Innovation and Hybrid Gamma-Optical Imaging Clinical Application Pathways for Sentinel Lymph Node Mapping and Intraoperative Tumor Localization Mobile Nuclear Imaging in Hospital, Surgical, and Bedside Environments Product Development and Industry Milestones During 2026